Largest biotech companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Amgen leads the 17 biotech companies in the United States ranked by revenue, at ZAR 646.3B, ahead of Gilead Sciences (ZAR 517.8B) and Biogen (ZAR 173.9B). Figures as of 21 Nov 2026, 00:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 17
- First
- AmgenZAR 646.3B
- Median
- ZAR 13B
- Combined market value
- ZAR 12.8T
- Countries
- 1
- Not ranked
- 3no revenue on file
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | ZAR 646.3B | ZAR 4.14T | ZAR 7,660.99 | 0.15% down | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | ZAR 517.8B | ZAR 3.63T | ZAR 2,926.77 | 0.06% down | 31% up | ||
| 3 | BiogenBIIB · Health Care | ZAR 173.9B | ZAR 648.8B | ZAR 4,389.19 | 1.00% up | 41% up | ||
| 4 | Neurocrine BiosciencesNBIX · Health Care | ZAR 50.3B | ZAR 268B | ZAR 2,647.86 | 3.84% down | 10% up | ||
| 5 | ExelixisEXEL · Health Care | ZAR 40.8B | ZAR 277.3B | ZAR 1,136.56 | 1.82% down | 55% up | ||
| 6 | ModernaMRNA · Health Care | ZAR 34.2B | ZAR 1.39T | ZAR 3,429.19 | 2.17% down | 740% up | ||
| 7 | Halozyme TherapeuticsHALO · Health Care | ZAR 24.6B | ZAR 183.2B | ZAR 1,606.44 | 1.82% down | 32% up | ||
| 8 | Bio-TechneTECH · Health Care | ZAR 21.4B | ZAR 200.8B | ZAR 1,277.95 | 0.04% down | 18% up | ||
| 9 | RepligenRGEN · Health Care | ZAR 13B | ZAR 184.1B | ZAR 2,880.70 | 3.81% down | 5% up | ||
| 10 | Krystal BiotechKRYS · Health Care | ZAR 6.8B | ZAR 161B | ZAR 5,432.02 | 2.19% down | 49% up | ||
| 11 | Twist BioscienceTWST · Health Care | ZAR 6.6B | ZAR 123.9B | ZAR 1,816.94 | 7.44% down | 291% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | ZAR 4.9B | ZAR 79.5B | ZAR 491.17 | 0.43% down | 51% up | ||
| 13 | ImmunityBioIBRX · Health Care | ZAR 2B | ZAR 112.6B | ZAR 105.87 | 8.37% down | 216% up | ||
| 14 | Kymera TherapeuticsKYMR · Health Care | ZAR 689.5M | ZAR 173.1B | ZAR 2,027.80 | 3.42% down | 81% up | ||
| 15 | CG OncologyCGON · Health Care | ZAR 71M | ZAR 124.8B | ZAR 1,397.53 | 2.97% down | 93% up | ||
| 16 | Revolution MedicinesRVMD · Health Care | ZAR 0 | ZAR 613.1B | ZAR 2,834.80 | 1.11% up | 125% up | ||
| 17 | Scholar Rock HoldingSRRK · Health Care | ZAR 0 | ZAR 103.3B | ZAR 846.39 | 4.45% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.5856 ZAR). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which biotech companies in the United States rank first by revenue?
Amgen (ZAR 646.3B), Gilead Sciences (ZAR 517.8B) and Biogen (ZAR 173.9B) are the top three of the 17 biotech companies in the United States ranked by revenue as of 21 Nov 2026, 00:16 UTC.
How many biotech companies in the United States are in this ranking?
17 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these biotech companies in the United States worth together?
The 17 biotech companies in the United States ranked by revenue have a combined market value of ZAR 12.8T as of 21 Nov 2026, 00:16 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies in the United States by revenue”, data as of 21 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.